These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20530685)

  • 21. Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.
    Yeow ZY; Lambrus BG; Marlow R; Zhan KH; Durin MA; Evans LT; Scott PM; Phan T; Park E; Ruiz LA; Moralli D; Knight EG; Badder LM; Novo D; Haider S; Green CM; Tutt ANJ; Lord CJ; Chapman JR; Holland AJ
    Nature; 2020 Sep; 585(7825):447-452. PubMed ID: 32908313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J; Ingram CD
    Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-specific hyperactive low-molecular-weight cyclin E isoforms detection and characterization in non-metastatic colorectal tumors.
    Corin I; Di Giacomo MC; Lastella P; Bagnulo R; Guanti G; Simone C
    Cancer Biol Ther; 2006 Feb; 5(2):198-203. PubMed ID: 16397408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of Cyclin E and its Low Molecular Weight Isoforms Cooperate with Loss of p53 in Promoting Oncogenic Properties of MCF-7 Breast Cancer Cells.
    Montazeri H; Bouzari S; Azadmanesh K; Ostad SN; Ghahremani MH
    Asian Pac J Cancer Prev; 2015; 16(17):7575-82. PubMed ID: 26625764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
    Lentini L; Amato A; Schillaci T; Di Leonardo A
    BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.
    Duong MT; Akli S; Macalou S; Biernacka A; Debeb BG; Yi M; Hunt KK; Keyomarsi K
    Cancer Res; 2013 Sep; 73(17):5556-68. PubMed ID: 23955388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
    Cheng X; Shen Z; Yang J; Lu SH; Cui Y
    J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centrosome amplification, chromosome instability and cancer development.
    Fukasawa K
    Cancer Lett; 2005 Dec; 230(1):6-19. PubMed ID: 16253756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight cyclin E: the missing link between biology and clinical outcome.
    Akli S; Keyomarsi K
    Breast Cancer Res; 2004; 6(5):188-91. PubMed ID: 15318923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
    Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
    Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Centrosome amplification and the origin of chromosomal instability in breast cancer.
    Salisbury JL; D'Assoro AB; Lingle WL
    J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):275-83. PubMed ID: 15557800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin E deregulation is an early event in the development of breast cancer.
    Shaye A; Sahin A; Hao Q; Hunt K; Keyomarsi K; Bedrosian I
    Breast Cancer Res Treat; 2009 Jun; 115(3):651-9. PubMed ID: 19107593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centrosome hyperamplification and chromosomal damage after exposure to radiation.
    Kawamura K; Fujikawa-Yamamoto K; Ozaki M; Iwabuchi K; Nakashima H; Domiki C; Morita N; Inoue M; Tokunaga K; Shiba N; Ikeda R; Suzuki K
    Oncology; 2004; 67(5-6):460-70. PubMed ID: 15714003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer.
    Akli S; Zhang XQ; Bondaruk J; Tucker SL; Czerniak PB; Benedict WF; Keyomarsi K
    Cell Cycle; 2012 Apr; 11(7):1468-76. PubMed ID: 22441703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.
    Doostan I; Karakas C; Kohansal M; Low KH; Ellis MJ; Olson JA; Suman VJ; Hunt KK; Moulder SL; Keyomarsi K
    Clin Cancer Res; 2017 Dec; 23(23):7288-7300. PubMed ID: 28947566
    [No Abstract]   [Full Text] [Related]  

  • 36. The low molecular weight (LMW) isoforms of cyclin E deregulate the cell cycle of mammary epithelial cells.
    Wingate H; Bedrosian I; Akli S; Keyomarsi K
    Cell Cycle; 2003; 2(5):461-6. PubMed ID: 12963845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression.
    Mussman JG; Horn HF; Carroll PE; Okuda M; Tarapore P; Donehower LA; Fukasawa K
    Oncogene; 2000 Mar; 19(13):1635-46. PubMed ID: 10763820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
    Guo X; Hartley RS
    Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.
    Piemonte KM; Anstine LJ; Keri RA
    Endocrinology; 2021 Dec; 162(12):. PubMed ID: 34606589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CEP135 isoform dysregulation promotes centrosome amplification in breast cancer cells.
    Ganapathi Sankaran D; Stemm-Wolf AJ; Pearson CG
    Mol Biol Cell; 2019 May; 30(10):1230-1244. PubMed ID: 30811267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.